天宇股份：坎地沙坦酯片获得药品注册证书

Group 1 - The core point of the article is that Tianyu Co., Ltd. has received approval from the National Medical Products Administration for the drug registration certificate of Candesartan Cilexetil Tablets, which are indicated for primary hypertension [1] Group 2 - The approval was granted to Zhejiang Norde Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Tianyu Co., Ltd. [1] - Candesartan Cilexetil Tablets are specifically used for the treatment of primary hypertension [1]